MidFirst Bank’s Edwards Lifesciences EW Stock Holding History

MidFirst Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$317K	Buy	3,506 +14	+0.4%	+$1.17K	0.02%	243
2026 Q1	$280K	Hold	3,492	–	–	0.02%	256
2025 Q4	$298K	Buy	+3,492	New	+$287K	0.02%	278

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

MidFirst Bank's EW Position: Q2 2026 in Review

MidFirst Bank increased its Edwards Lifesciences (EW) stake by 0.4% in Q2 2026, buying an estimated $1.17K and bringing the position to 3,506 shares worth $317K. The position accounts for 0.02% of the portfolio, ranked #243.

MidFirst Bank first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,096 funds tracked by Wall St. Rank hold EW as of Q2 2026.

MidFirst Bank held 3,506 shares of Edwards Lifesciences worth $317K as of Q2 2026.
MidFirst Bank bought 14 Edwards Lifesciences shares in Q2 2026, an estimated $1.17K.
Edwards Lifesciences made up 0.02% of MidFirst Bank's portfolio in Q2 2026, its #243 holding.
MidFirst Bank first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
1,096 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.